Zhejiang Tailin BioEngineering Co.,Ltd

¥18.71As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300813Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (3.42%)
Div yield 0.69%
ROE 3.74%
Medical Devices
Beta (5Y) 1.37
PE TTM 73.54
TSR TTM (36.97%)
Mkt cap ¥2.245B
ROIC 4.20%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥19
3.53%
(54.83%)
Hold 0|4|11|6|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.27
0.26
0.27
0.25
17.13%
10.60%
10.59%
5.92%
Revenue¥M
158.9
167.5
176.0
185.8
3.46%
6.37%
12.10%
17.17%
Peers (US$336.5M)
Cap (US$)
PE
349.4M
27.27x
321.2M
25.74x
Capital
TTM
5Y
10Y
Leveragex
4.021
0.414
0.418
EBIT/Intx
1.173
0.375
0.502
Own earn%
50.19
(41.66)
(41.41)
Sh yield%
5.04
14.31
13.38
Owners
Insiders/Inst%
11.77
53.39
Short interest%
1.83
SBC / revenue%
1.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
0–13
$1 testx
−0.1
Incr. ROIC%
1